Today: 23 May 2026

USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape

USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape

USA Rare Earth shares surged 16% to $25.64 midday Tuesday after President Trump announced “Project Vault,” a $12 billion plan to stockpile critical minerals. The initiative includes a $10 billion Ex-Im Bank loan and $2 billion from private investors. Commodities traders Hartree, Traxys, and Mercuria will handle procurement. Other rare earth stocks also rose sharply.
3 February 2026
·
GE Aerospace stock flat as Boeing 777X GE9X seal issue, Singapore repair push grab attention

GE Aerospace stock flat as Boeing 777X GE9X seal issue, Singapore repair push grab attention

GE Aerospace shares edged up 0.04% Tuesday after the company disclosed a possible durability issue with a seal on its GE9X engine for Boeing’s 777X. GE plans to invest up to $300 million expanding its Singapore engine-repair operations, adding automation and AI inspection tools. Moody’s upgraded GE Aerospace’s senior unsecured rating to A2, citing a positive outlook.
3 February 2026
··
ServiceNow stock slides again as AI disruption fears rattle software — what investors watch next

ServiceNow stock slides again as AI disruption fears rattle software — what investors watch next

ServiceNow shares fell 8.1% to $108.40 in midday trading Tuesday, leading declines as software stocks sold off. The S&P 500 software and services index dropped 3.3% amid renewed concerns about AI disruption. Investors cited the rollout of new AI tools and upcoming earnings from Alphabet and Amazon as key drivers. ServiceNow last week announced a $7.75 billion deal for Armis and raised its share buyback program.
3 February 2026
··
Merck stock rises despite cautious 2026 outlook as patent losses loom

Merck stock rises despite cautious 2026 outlook as patent losses loom

Merck shares rose 3.1% to $116.86 after fourth-quarter earnings beat estimates, with Keytruda sales up 7% to $8.37 billion. The company forecast 2026 sales of $65.5–$67.0 billion, below Wall Street expectations, citing patent expirations and pricing pressure. Gardasil sales fell 34% to $1.03 billion. The FDA accepted Merck’s application for Winrevair, with a decision expected by September 2026.
3 February 2026
··
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita shares rose nearly 20% to $132.98 after the company projected 2026 adjusted earnings per share of $13.60–$15.00, above analyst estimates. Fourth-quarter adjusted EPS reached $3.40 on revenue of $3.62 billion, both topping forecasts. The company cited higher reimbursement rates and a seasonal boost from flu vaccines. DaVita flagged a $40 million hit in 2026 from expiring ACA subsidies.
3 February 2026
··
PepsiCo stock jumps as Lay’s and Doritos price cuts hit shelves after earnings beat

PepsiCo stock jumps as Lay’s and Doritos price cuts hit shelves after earnings beat

PepsiCo shares rose 3.7% to $160.99 Tuesday after the company cut U.S. snack prices and beat quarterly revenue and earnings forecasts. The company raised its dividend, confirmed 2026 targets, and approved a new $10 billion share buyback. Snack prices on brands like Lay’s and Doritos are dropping up to 15% this week. Investors are watching if lower prices will lift North American volumes before the Super Bowl.
3 February 2026
··
KLA stock slides as chip-equipment names retreat; shutdown jitters and megacap earnings in focus

KLA stock slides as chip-equipment names retreat; shutdown jitters and megacap earnings in focus

KLA shares fell 4.5% to $1,346.85 by midday Tuesday, underperforming other chip-equipment stocks as tech shares broadly declined. The partial U.S. government shutdown delayed key labor-market data, adding uncertainty for investors. Alphabet and Amazon earnings this week are in focus for signals on AI and cloud spending.
3 February 2026
········
Applied Materials stock slips despite fresh Wall Street target hikes — what’s behind AMAT’s move

Applied Materials stock slips despite fresh Wall Street target hikes — what’s behind AMAT’s move

Applied Materials shares fell about 2% to $321.73 by midday Tuesday amid a broader tech sell-off. UBS and Morgan Stanley raised their price targets for the stock ahead of Applied’s February 12 earnings report. Investors are watching for guidance on April-quarter revenue and updates on China exposure. Chip-equipment peers ASML, KLA, and Lam Research also declined.
3 February 2026
··
Novo Nordisk warns 2026 sales could fall — and the Wegovy pill isn’t saving the mood yet

Novo Nordisk warns 2026 sales could fall — and the Wegovy pill isn’t saving the mood yet

Novo Nordisk forecast 2026 adjusted sales and operating profit will fall 5%–13% at constant exchange rates, citing pricing pressure and competition. U.S.-listed shares dropped about 12% after the outlook. The company reported 2025 sales up 10% to 309.1 billion Danish crowns and operating profit up 6%. Early U.S. uptake of its Wegovy pill was noted, but patent expiries and lower realized prices remain concerns.
3 February 2026
·
Chevron stock rises even after HSBC downgrade as oil steadies and Venezuela exports jump

Chevron stock rises even after HSBC downgrade as oil steadies and Venezuela exports jump

Chevron shares rose 1.4% to $176.50 by midday Tuesday, rebounding after a 1.6% drop. Oil prices edged higher as U.S.-Iran diplomacy talks resumed and Venezuelan exports surged to 800,000 barrels per day in January. Chevron shipped 220,000 barrels per day to the U.S., more than double the previous month. Investors are watching upcoming U.S.-Iran talks and potential Treasury decisions on Venezuelan oil licenses.
3 February 2026
···
1 … 408 409 410 411 412 … 1,971

Stock Market Today

  • Berkshire Hathaway (BRK.B) Valuation Examined Amid Undervaluation Claims
    May 22, 2026, 10:01 PM EDT. Berkshire Hathaway (BRK.B) closed at US$486.38 after a 4.5% gain in the past month, despite a 2.4% decline over three months. The stock trades about 36.5% below an intrinsic value estimate of US$669,764.35, fueling a narrative that it is significantly undervalued. This estimate factors in optimistic revenue growth, strong profit margins, and elevated price-to-earnings (P/E) multiples typical of faster-growing sectors. However, analysts caution that these assumptions risk being overly bullish, as any earnings setbacks or shifts in market sentiment could diminish the stock's premium valuation outlook. Berkshire's longer-term shareholder returns - 51.7% over three years and 68.0% over five years - underline sustained momentum, but investors are advised to critically assess this mix of optimism amid potential risks.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
Go toTop